DSC_0613-862×576

Canadian Diplomat returns to AIMS for Industry Summit

The African Institute for Mathematical Sciences – Next Einstein Initiative (AIMS-NEI), welcomed back Canadian High Commissioner Sara Hradecky for an industry summit in Kigali on Jan. 12. “AIMS centres of excellence, including the one here in Kigali, contribute to building Africa’s human capital,” said High Commissioner Hradecky. The event was supported by the Government of […]

AIMS-BK-MOU

AIMS partners with Bank of Kigali for Industry Initiative

The Bank of Kigali and the African Institute for Mathematical Sciences (AIMS) signed a five-year deal to match financial services opportunities with graduates skilled in mathematical sciences. The partnership encourages AIMS graduates to work on bank business problems and develop solutions by designing prototypes for new products and services to support the Bank of Kigali’s […]

AIMS-ESMT-graduation

AIMS-ESMT program boosts graduate employment skills

Twenty-five African Institute for Mathematical Sciences (AIMS) students from eight African countries received their certificates for completing the AIMS ESMT Industry Immersion Program (IIP) on Dec. 1. “Through your internships you prove your value to African industry,” said Nick Barniville, ESMT Berlin Associate Dean of Programs. He added that visiting ESMT faculty had found it […]

Canadian-ambassador-AIMS-industry-intiative-partnership-event-862×485

Canadian Embassy in Senegal joins AIMS for Industry Event

The Canadian Embassy in Senegal and the African Institute for Mathematical Sciences – Next Einstein Initiative (AIMS-NEI) held an industry partnership event on Oct 26. The event was hosted by Her Excellency Lise Filiatrault, Canadian Ambassador in Senegal,  at her Official Residence in Dakar. The showcase came to be with the support of the Government […]

GSK-logo-2014

GlaxoSmithKline Research and Development invests in AIMS Industry Initiative

The African Institute for Mathematical Sciences-Next Einstein Initiative (AIMS-NEI) received a $66,000 investment from GlaxoSmithKline, Research & Development Ltd. (GSK R&D). The funds will be used for research in health care access, medical or scientific education, life sciences and progress in the prevention, treatment and management of disease. “One of the goals of the AIMS is […]